Navigation Links
Massage Chair Distributor Inada USA Now Sponsoring National Public Radio (NPR)
Date:7/30/2013

BOULDER, Colo., July 30, 2013 /PRNewswire/ -- Inada USA, the exclusive U.S. distributor of award-winning Inada brand massage chairs, announced today that it has become a corporate sponsor of National Public Radio (NPR). Underwriting messages began airing on July 29, 2013.

Inada's sponsorship announcements will be heard on NPR's Morning EditionAll Things ConsideredCar Talk and Weekend Edition. NPR has 27 million weekly listeners and more than 19 million monthly visitors to NPR.org.

"We are long-time fans of public radio, and NPR in particular," said Cliff Levin, president of Inada USA. "We are glad to be able to support and sponsor such a great source of news, music and ideas."

The announcement crediting Inada USA for its underwriting support will direct listeners to www.DreamWaveChair.com. When visiting the site, listeners will be able to learn more about the award-winning Sogno DreamWave™ massage chair, order it online or be directed to the nearest authorized Inada dealer.

"Inada seeks to educate consumers about the benefits of massage, just as NPR seeks to educate its listeners about the world around them," Levin added. "This is a natural association for both Inada USA and NPR. Inada customers and NPR listeners are demographically very similar—people who are interested in health and wellness." 

About Inada USA

Inada USA distributes therapeutic massage chairs through an exclusive relationship with the Family Inada company of Osaka, Japan. Inada massage chairs combine shiatsu master massage movements with state-of-the-art Japanese engineering. Utilizing a patented body sc
'/>"/>

SOURCE Inada USA
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Medicare Policies Restricting Power Wheelchair Repairs Leave Vulnerable Beneficiaries with Limited Mobility
2. Suture Express Announces New Board Chairman
3. Wheelchair Repair service offered by Numotion for former Alliance Seating & Mobility Customers
4. Royalty Pharma Chairman Writes Open Letter to Elan Board
5. Regulus Names Stelios Papadopoulos, Ph.D. as Chairman of its Board of Directors
6. Oclaro Announces Retirement Of Chairman And CEO Alain Couder; Names Greg Dougherty CEO And Marissa Peterson Chair
7. AMRI Announces Appointment of William Marth as Chairman of the Board of Directors
8. Phoenix House Honors Allergan Chairman David Pyott And Legendary Sports Agent And Humanitarian, Leigh Steinberg
9. Hanger elects Thomas P. Cooper, M.D. Chairman of the Board
10. CardioMEMS Vice President - Information Systems, Richard Powers, and Chairman of the Board, John Huntz, Selected as Finalists for Prestigious Awards
11. MedAllies CEO A. John Blair III, MD, elected DirectTrust chair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... CAMBRIDGE, Mass. , Jan. 15, 2014 /PRNewswire/ ... addressing the unmet needs of severely obese patients, ... study of beloranib, a selective inhibitor of methionine ... (PWS), a severe form of genetic obesity.  These ... and body composition, including reductions in body fat ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . ... of less invasive, miniaturized circulatory support technologies that ... today announced that it expects revenues for the ... million, bringing expected full-year 2013 revenues to approximately ... of 87% for 2013 above 2012 reflects the ...
(Date:1/14/2014)... , Jan. 14, 2014 InformEx, ... for buyers and sellers of high-value chemistry, will hold ... at the Miami Beach Convention ... ) More than 3,500 attendees from ... take part in the conference, which includes on-site education ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... Imagenetix, Inc. (OTC Bulletin Board: IAGX ) announced today ... Net sales decreased 4% for the third quarter of fiscal year ... year. A loss of $1,202,000, $0.10 per share, was reported for ... loss of $294,000, $.03 per share, for the same period of ...
... Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China ... and markets specialty pharmaceutical products in China, today announced that ... before the market opens on Thursday, March 3, 2011. ... 8:30 am ET on March 3, 2011 to discuss fiscal ...
Cached Medicine Technology:Imagenetix, Inc. Reports Third Quarter 2011 Results 2Imagenetix, Inc. Reports Third Quarter 2011 Results 3China Pharma Holdings, Inc. to Report Fiscal Year 2010 Financial Results on March 3, 2011 2
(Date:4/14/2014)... In a UT Dallas study involving serious youth offenders, the ... for the next seven years: "How long do you think ... the future encourages offending over time., Author Dr. Alex Piquero ... long life ahead of them offend at very high rates ... going to die much later in life offend much less., ...
(Date:4/14/2014)... Ohio A new study identifies a molecule that ... suggests that the molecule could be an important target ... tumor progression. , The study of microRNA-135b (miR-135b) in ... the journal Cancer Cell and was led ... Center Arthur G. James Cancer Hospital and Richard ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... WASHINGTON, April 14In dense, urban centers around the world, ... streets surrounded by tall buildings that block sunlight. And ... are jammed closer together, the darkness will only spread. ... developed a corrugated, translucent panel that redirects sunlight onto ... rooftops and hung over the edge at an angle, ...
(Date:4/14/2014)... aren,t breastfed or not breastfed for long are ... related health problems later in life, according to ... to hypothesize that breastfeeding was important to influencing ... (Northwestern University), a CIFAR (Canadian Institute for Advanced ... program. "It changes the microbiome. It promotes development ...
Breaking Medicine News(10 mins):Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Study identifies a likely key driver of colorectal cancer development and progression 2Health News:Young dads at high risk of depression, too 2Health News:Let the sun shine in: Redirecting sunlight to urban alleyways 2Health News:Low birth weight, less breastfeeding create later health risks 2
... how hypertension is treated, experts say , SUNDAY, March ... large five-year study points to fluctuations in blood pressure ... , In the study, British researchers tracked the health ... or calcium channel blocker medication to curb high blood ...
... traditional screening tests for potential anti-cancer drugs, scientists ... technique that more closely simulates the real-world conditions ... normal cells. Because these neighboring cells key ... microenvironment" can alter the effectiveness of anti-cancer ...
... fewer side effects than the conventional medication used during a ... a Henry Ford Hospital study. Researchers say the 25 ... such as abnormally low blood pressure or slow heart beat ... Additionally, patients showed no signs of heart block, a condition ...
... exam, study finds , SUNDAY, March 14 (HealthDay News) -- ... and collegiate hockey players in a U.S. study had abnormal ... see if abnormal MRI results are found incidentally in active ... the department of family medicine and orthopedics at Hershey Medical ...
... no effect in shielding users from cardiovascular woes, study ... that two available drugs could help prevent diabetes and ... sugar metabolism have been dashed by a major international ... other reasons -- Diovan (valsartan), a blood pressure medication; ...
... pressure to normal levels below currently recommended levels ... fatal or nonfatal cardiovascular disease events in adults with ... for cardiovascular disease events, according to new results from ... (ACCORD) clinical trial. Similarly, treating multiple blood lipids with ...
Cached Medicine News:Health News:More Evidence That Swings in Blood Pressure Raise Stroke Risk 2Health News:New cancer drug screening technique more closely mirrors reality 2Health News:New cancer drug screening technique more closely mirrors reality 3Health News:Scans May Be Misleading for Hockey Players 2Health News:2 Drugs Fail to Prevent Diabetes in the Overweight 2Health News:2 Drugs Fail to Prevent Diabetes in the Overweight 3Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 2Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 3Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 4Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 5Health News:ACCORD: Intensive BP, combined lipid therapies do not help adults with diabetes 6
The Emit 2000 Digoxin Calibrators are intended for use with the Emit 2000 Digoxin Assay....
... The BD Macro-Vue RPR (Rapid Plasma ... Tear-drop Tests are nontreponemal testing procedures ... described in A Manual of Tests ... this manual are the most widely ...
Agglutination test on slide for qualitative and quantitative determination of Syphilis in serum or plasma....
... quality assurance reagent in assays detecting IgG and ... TOXO IgM), IgG and IgM antibodies to rubella ... IgM antibodies to cytomegalovirus (CMV IgG and IgM), ... virus types 1 and 2 (HSV-1 IgG, HSV-1 ...
Medicine Products: